These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1077 related items for PubMed ID: 9591710

  • 1. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 2. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
    Evans TG, Bonnez W, Soucier HR, Fitzgerald T, Gibbons DC, Reichman RC.
    Antiviral Res; 1998 Oct 01; 39(3):163-73. PubMed ID: 9833957
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR, Zaunders JJ, Cunningham P, Kelleher AD, Grey P, Smith D, Carr A, Cooper DA.
    AIDS; 2000 Dec 01; 14(17):2643-51. PubMed ID: 11125882
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ, Cunningham PH, Kelleher AD, Kaufmann GR, Jaramillo AB, Wright R, Smith D, Grey P, Vizzard J, Carr A, Cooper DA.
    J Infect Dis; 1999 Aug 01; 180(2):320-9. PubMed ID: 10395845
    [Abstract] [Full Text] [Related]

  • 7. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec 01; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 8. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S, Galán I, Bellón JM, Navarro ML, León JA, Muñoz-Fernandez MA.
    J Clin Immunol; 2003 Jul 01; 23(4):279-89. PubMed ID: 12959220
    [Abstract] [Full Text] [Related]

  • 9. Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells.
    Gray CM, Lawrence J, Ranheim EA, Vierra M, Zupancic M, Winters M, Altman J, Montoya J, Zolopa A, Schapiro J, Haase AT, Merigan TC.
    AIDS Res Hum Retroviruses; 2000 Sep 20; 16(14):1357-69. PubMed ID: 11018855
    [Abstract] [Full Text] [Related]

  • 10. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR, Cone RW, Huber W, Battegay M, Vernazza PL, Weber R, Grob PJ, Opravil M.
    AIDS; 1998 Nov 12; 12(16):2115-23. PubMed ID: 9833852
    [Abstract] [Full Text] [Related]

  • 11. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
    Choremi-Papadopoulou H, Tsalimalma K, Dafni U, Dimitracopoulou A, Kordossis T.
    J Med Virol; 2004 Jun 12; 73(2):235-43. PubMed ID: 15122798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
    Wu H, Connick E, Kuritzkes DR, Landay A, Spritzler J, Zhang B, Spear GT, Kessler H, Lederman MM, ACTG 315 Team.
    AIDS Res Hum Retroviruses; 2001 Sep 01; 17(13):1231-40. PubMed ID: 11559422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R, Kinloch S, Goh LE, Cooper D, Perrin L, Lampe F, Zaunders J, Hoen B, Tsoukas C, Andersson J, Janossy G, Quest Study Group.
    AIDS; 2002 Mar 08; 16(4):589-96. PubMed ID: 11873002
    [Abstract] [Full Text] [Related]

  • 16. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
    Jankelevich S, Mueller BU, Mackall CL, Smith S, Zwerski S, Wood LV, Zeichner SL, Serchuck L, Steinberg SM, Nelson RP, Sleasman JW, Nguyen BY, Pizzo PA, Yarchoan R.
    J Infect Dis; 2001 Apr 01; 183(7):1116-20. PubMed ID: 11237839
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR, Zaunders JJ, Cunningham P, Cooper DA.
    AIDS Res Hum Retroviruses; 1999 Jul 20; 15(11):963-72. PubMed ID: 10445808
    [Abstract] [Full Text] [Related]

  • 18. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
    Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A.
    AIDS; 2000 May 05; 14(7):761-70. PubMed ID: 10839583
    [Abstract] [Full Text] [Related]

  • 19. Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
    Plana M, Martínez C, García F, Maleno MJ, Barceló JJ, García A, Lejeune M, Vidal C, Cruceta A, Miró JM, Pumarola T, Gallart T, Gatell JM.
    J Acquir Immune Defic Syndr; 2002 Apr 15; 29(5):429-34. PubMed ID: 11981357
    [Abstract] [Full Text] [Related]

  • 20. Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations.
    Nokta M, Rossero R, Nichols J, Rosenbaum M, Pollard RB.
    AIDS Res Hum Retroviruses; 1999 Feb 10; 15(3):255-64. PubMed ID: 10052756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.